Welcome to our dedicated page for Exponent SEC filings (Ticker: EXPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The EXPO SEC filings page on Stock Titan provides access to Exponent, Inc.’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed science and engineering consulting firm, Exponent uses SEC reports to present detailed information about its financial condition, operating performance, and material events. These filings complement the company’s earnings releases and offer structured data on revenues before reimbursements, operating expenses, segment performance, and non-GAAP measures such as EBITDA and EBITDAS.
Investors can use this page to locate Exponent’s periodic reports, including annual and quarterly filings that discuss its two operating segments: the engineering and other scientific segment and the environmental and health segment. These documents describe how much each segment contributes to revenues before reimbursements and provide narrative explanations of demand trends in areas such as dispute-related services, risk management projects, and regulatory consulting across industries like construction, automotive, medical devices, utilities, chemicals, transportation, and life sciences.
The EXPO filings page also highlights current reports on Form 8-K, where Exponent discloses material events. Recent 8-K filings have incorporated press releases announcing quarterly financial results, dividend declarations, and changes to share repurchase authorizations. These filings give timely insight into board decisions on capital returns and into management’s assessment of market conditions and business performance.
Stock Titan enhances access to these documents with AI-powered summaries that explain key sections in plain language, helping readers interpret complex accounting and technical terminology. Users can quickly see how Exponent’s reported metrics, segment data, and capital allocation actions fit into its broader consulting business. This makes the EXPO SEC filings page a useful starting point for understanding Exponent’s regulatory history and ongoing reporting as a professional, scientific, and technical services company.
Exponent reported modest top-line growth with mixed profitability. Second-quarter revenues were $141,962,000, up 1% year-over-year, driven by higher billing rates in engineering services. Net income fell 9% to $26,553,000 and diluted EPS declined to $0.52 from $0.57, reflecting higher compensation-related costs and lower utilization.
The firm generated $43,496,000 of operating cash flow in the first six months and held $231,801,000 in cash and cash equivalents at period end. Billable hours declined 6% and utilization fell to 72%, while a large change in the fair value of deferred compensation plan assets increased other income but also raised corporate compensation expense, materially reducing operating income for the quarter. The company continued shareholder returns via $0.30 per-share quarterly dividend and increased share repurchases ($32.68M year-to-date).